RAIN Rain Oncology Inc.

NASDAQ
$0.88

Rain Oncology Inc. (RAIN) Institutional Ownership

What the institutions did with RAIN last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting
1
filed a 13F this quarter
Managers holding
0
-1 on the quarter
Buyers
0
0 opened new
Sellers
1
1 sold out entirely
Buyer share
0.0%
of managers who traded it
Breadth
-100.0
net buyers, as a share of those trading

Only 1 managers reported a position this quarter, so the percentages above describe a very small sample.

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
Meteora Capital, LLC 585.8K 64.9%
Knott David M Jr 101.7K 11.3%
VANGUARD CAPITAL MANAGEMENT LLC 39.6K 4.4%
JPMORGAN CHASE & CO 39.2K 4.3%
GEODE CAPITAL MANAGEMENT, LLC 27.8K 3.1%
Polar Asset Management Partners Inc. 24.0K 2.7%
Magnetar Financial LLC 24.0K 2.7%
Apollo Management Holdings, L.P. 24.0K 2.7%
VANGUARD FIDUCIARY TRUST CO 17.2K 1.9%
UBS Group AG 14.7K 1.6%
Tower Research Capital LLC (TRC) 3.0K 0.3%
MORGAN STANLEY 950 0.1%
CITIGROUP INC 274 0.0%
WOLVERINE ASSET MANAGEMENT LLC 77 0.0%
SBI Securities Co., Ltd. 18 0.0%
Caitong International Asset Management Co., Ltd 3 0.0%

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.